|
Volumn 26, Issue 4, 2014, Pages 409-410
|
Anesthesia with antiamoebic effects: Can anesthesia choice affect the clinical outcome of granulomatous amoebic encephalitis due to acanthamoeba spp.?
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DROPERIDOL PLUS FENTANYL;
HALOPERIDOL;
LOPERAMIDE;
NEUROLEPTIC AGENT;
ACANTHAMOEBA;
ACANTHAMOEBA CASTELLANII;
ACANTHAMOEBA KERATITIS;
ANESTHESIA;
ANTIAMEBIC ACTIVITY;
BLOOD BRAIN BARRIER;
DRUG ACTIVITY;
DRUG EFFICACY;
ELECTROCORTICOGRAPHY;
GRANULOMATOUS AMEBIC ENCEPHALITIS;
HIGH RISK PATIENT;
HOSPITAL ADMISSION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
IN VITRO STUDY;
LETTER;
NEUROLEPTANALGESIA;
PRIORITY JOURNAL;
AMEBIASIS;
DRUG EFFECTS;
DRUG POTENTIATION;
ENCEPHALITIS;
GRANULOMA;
PARASITOLOGY;
PROCEDURES;
ACANTHAMOEBA;
AMEBIASIS;
ANESTHESIA;
ANTIPSYCHOTIC AGENTS;
DRUG SYNERGISM;
ENCEPHALITIS;
GRANULOMA;
HALOPERIDOL;
HUMANS;
LOPERAMIDE;
|
EID: 84925871610
PISSN: 08984921
EISSN: 15371921
Source Type: Journal
DOI: 10.1097/ANA.0000000000000036 Document Type: Letter |
Times cited : (2)
|
References (6)
|